CARL B. FELDBAUM - 19 Nov 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
19 Nov 2021
Net transactions value
-$289,800
Form type
4
Filing time
23 Nov 2021, 19:11:55 UTC
Previous filing
28 May 2021
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $62,600 +20,000 +235% $3.13 28,521 19 Nov 2021 Direct
transaction EXEL Common Stock Sale $352,400 -20,000 -70% $17.62 8,521 19 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -20,000 -50% $0.000000 20,000 19 Nov 2021 Common Stock 20,000 $3.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.57 to $17.68. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2 The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015.